Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Who got their package?
So I read packages are in the mail?? Who is ready to get PAID!?
Zero dollars and Zero cents
WHO IS READY TO GET PAID!!!!!!!!?????
This must be the week, I can feel it...
13 years later, and I am still sitting on my porch waiting for my package to arrive. You would think they would have paid for expedited shipping.
Anyone else hear we are getting around $7 per share by end of month? I already spent it on credit and will be up the creek without a paddle if we aren't.
y so low, I heard $7?
That makes sense, wish I would have done the same. Oh well at least we should have checks in our hands by end of month.
I have about a thousand shares of this bad boy. From what I hear I should be getting a check for $7,000.
We are about to get paid and you guys are talking tortilla chips??
Sounds like the long awaited payout is this month, I am waiting on my porch for it as we speak.
Dilly Dilly!
According to the call with Steve in late December he said there is no money anywhere. The only chance you have to get your money back or maybe even make a little profit is if it trades again. Why do a lot of people still think we are going to be rich?
Why are people still even talking about this? It has been dead for over 10 years. Why would you even think you would get any money out of this old scam?
What is the deal here? I thought CMKX was toast? Is there an actual oil operation going on in Texas? Are we able to go see it at all? I have a relative that is close to Eastland county Tx right now.
What is the deal here? I thought CMKX was toast? Is there an actual oil operation going on in Texas? Are we able to go see it at all? I have a relative that is close to Eastland county Tx right now.
What is the deal here? I thought CMKX was toast? Is there an actual oil operation going on in Texas? Are we able to go see it at all? I have a relative that is close to Eastland county Tx right now.
I'd assume probably something to do with the shareholder meeting that was held today. Obviously something very well.
Today we could break 1.08
May test 1.20 tomorrow...
I think we test the 1.20s by Wednesday
Yes pretty much any IPO that goes down in price gets those "lawsuits" from lawyers looking to make money off the shareholders. Has had zero impact on price of stock from my experience.
Yea who knows what the patents are worth. If a buyer thinks the would get FDA approval probably several dollars per share? In addition to the $1.63 in net cash. Below is from their website not just for knee...
Pipeline (Other joints): We have focused our product development efforts on developing Hydros-TA for the treatment of osteoarthritis (OA) pain in the knee. As this program progresses along the path to regulatory approval in the United States, we may explore the potential use of Hydros-TA in treating pain in other joints affected by OA. Joints affected by OA include the finger, hip, shoulder, ankle and temporomandibular joints. The initial target for the next product development effort for OA may likely be the hip joint.
Still waaaay oversold from phase III results. Keep in mind that was not a complete failure and the patents may hold alot of value in addition to the $1.63 in NET cash. Check out this link.
http://www.streetinsider.com/dr/news.php?id=11270957
7 Reasons Why you want to own CBYL now…
They have $1.63 in NET cash per share after debt on hand as of 3/31. 48 million cash 5 million debt equals 43 million in net cash on hand after debt with 26 million shares outstanding.
They own patents for Hydros-TA worldwide which isn't just for knee pain but check out other future uses in pipeline section on our website.
Phase 3 was not a complete failure just missed 2nd endpoint because pain level at 26 weeks was equal to another method still better at beginning of trial.
Therefore, patents hold value, add that to the $1.63 in NET cash per share for acquisition or merger.
They are actively seeking acquisition or merger per PR on 4/15/16 and only have 3 employees to preserve cash stockpile. Goal is to close by the end of Q3, which means PR should be any day now.
ZERO preferred shares outstanding per 10q which means when they get paid we get paid, only common shareholders.
Their new institutional investor Vivo Capital LLC, newly reported as of 3/31/16 specializes in facilitating strategic alliances including creating cross border partnerships & facilitating acquisitions. They own over 4.2 million shares, over 15% of all outstanding shares.
Links
10q
http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=11382259&RcvdDate=5/12/2016&CoName=CARBYLAN%20THERAPEUTICS%2C%20INC.&FormType=10-Q&View=html
PR regarding seeking acquisition or merger
http://www.nasdaq.com/press-release/carbylan-therapeutics-announces-decision-to-pursue-strategic-transaction-20160415-00182
Link in regards to Vivo Capital LLC
http://www.fiercemedicaldevices.com/story/vivo-capital-doubles-down-close-750m-us-china-healthcare-fund/2015-03-18
Link to Product Pipeline
http://www.carbylan.com/innovation/product-pipeline
7 Reasons Why you want to own CBYL now…
We have $1.63 in NET cash per share after debt on hand as of 3/31. 48 million cash 5 million debt equals 43 million in net cash on hand after debt with 26 million shares outstanding.
We own patents for Hydros-TA worldwide which isn't just for knee pain but check out other future uses in pipeline section on our website.
Phase 3 was not a complete failure just missed 2nd endpoint because pain level at 26 weeks was equal to another method still better at beginning of trial.
Therefore, patents hold value, add that to the $1.63 in NET cash per share for acquisition or merger.
They are actively seeking acquisition or merger per PR on 4/15/16 and only have 3 employees to preserve cash stockpile. Goal is to close by the end of Q3, which means PR should be any day now.
ZERO preferred shares outstanding per 10q which means when they get paid we get paid, only common shareholders.
Our new institutional investor Vivo Capital LLC, newly reported as of 3/31/16 specializes in facilitating strategic alliances including creating cross border partnerships & facilitating acquisitions. They own over 4.2 million shares, over 15% of all outstanding shares.
Links
10q
http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=11382259&RcvdDate=5/12/2016&CoName=CARBYLAN%20THERAPEUTICS%2C%20INC.&FormType=10-Q&View=html
PR regarding seeking acquisition or merger
http://www.nasdaq.com/press-release/carbylan-therapeutics-announces-decision-to-pursue-strategic-transaction-20160415-00182
Link in regards to Vivo Capital LLC
http://www.fiercemedicaldevices.com/story/vivo-capital-doubles-down-close-750m-us-china-healthcare-fund/2015-03-18
Link to Product Pipeline
http://www.carbylan.com/innovation/product-pipeline
True but the volume picked back up today especially for a Friday. I remember Friday's where we only had a couple hundred thousand and volume.
How has it not? We were at 75 cents at this time last week. Chart couldn't look better.
$1.10+ Monday easy
The patents may very well hold alot of value as well. Also, there has been atleast two sub doller stocks aquired in the past two weeks. Both nearly doubled pre market the day they were announced. Alxa and wgbs
Good call....NOT
Buyout should be announced in the next couple weeks then a $1+.
Easily
Cbyl the next snta? I am expecting something very similar.
CBYL is next? Over 50 million NET cash on hand.
CBYL up over 5% on huge volume ready to explode IMO
cbyl Currently sitting at just under 64 cents and they have around $1.75 in net cash on hand. They also own patents on their hydro TA injection for knee osteoporosis.
Also float is around 1.25 million shares and last report showed 925k shares shorted.
We are currently sitting on around $1.75 per share. Meaning our minimum return unless they completely screw up should be around 300%. It should actually be much much higher than that with the patents we own. Be sure to reach out to them to make sure that they know we want answers on how they are going to proceed. Their email address is info@carbylan.com.
Has anyone else thought what if they did a one time divided of $1.25 per share? This would give us 13 million in cash to continue development and find a partner or be aquired. This would also keep us above the $1 bid price to keep our Nasdaq listing current.
The end of this statement tells me most likely the direction we are headed. There are many other things throughout the 10-k that point in this direction as well. It shouldn't take long with around 50 million in net cash on hand. Question again becomes how much are the patents worth, and add that to the appropriate $1.75 in cash on hand per share. My guess would be in the $3 to $6 per share range if we are acquired.
Since TA is an approved product in different pharmaceutical preparations, we may rely on the FDA’s prior findings of safety and efficacy for TA and, thus, the Hydros-TA new drug application, or NDA, could benefit from being filed under Section 505(b)(2) of the Federal Food, Drug and Cosmetic Act, or the FDCA, by eliminating the need for certain pre-clinical safety studies of TA. Hydros is considered a new molecular entity, or NME, and we are required to complete full pre-clinical testing to assure its safety profile. However, since Hydros-TA is our product candidate, not Hydros alone, in order to obtain regulatory approval of Hydros-TA, Hydros will not have to undergo any clinical testing independent of the Hydros-TA studies. While we are considering potential strategic alternatives, we are also considering the potential for the future clinical development of Hydros-TA.
Another reference to it throughout the 10-k
In March 2016, we engaged a financial and strategic advisor, Wedbush PacGrow, to advise us on strategic alternatives. Wedbush PacGrow will provide a range of advisory services aimed to enhance shareholder value. The alternatives to be considered will include the potential for an acquisition, merger, strategic partnership or other strategic transactions. We expect to devote substantial time and resources to exploring strategic alternatives, however, there can be no assurance that such activities will result in any agreements or transactions that will enhance shareholder value. Further, any strategic transaction that is completed ultimately may not deliver the anticipated benefits or enhance shareholder value.
Patents in 10-k
As of December 31, 2015, we have three issued U.S. patents and ten issued non-U.S. patents, the earliest of which will expire in 2030, and 25 patent applications worldwide covering our Hydros platform technology, including claims directed to composition of matter, methods of use and product-by-process.
I'd be surprised if we don't close over .70 today and wouldn't be shocked if we were around or over a dollar by eod Monday. Not only better than anyone expected but also on time.